Has Leslie Dieckhoff received payments from drug or device companies?

Yes. Drug and device makers reported $1,997 in general payments to Leslie Dieckhoff across 98 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leslie Dieckhoff did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leslie Dieckhoff come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leslie Dieckhoff

Adult Health · Louisville, KYNPI 1457663254

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $849 and has fallen 71.8% since, to $240 in 2024.

$1,997in general payments, 2019–2025

Across 98 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$458
Lilly USA, LLC$345
Takeda Pharmaceuticals U.S.A., Inc.$302
Esperion Therapeutics, Inc.$247
AbbVie$200
Sanofi-aventis U.S. LLC$133
plus $312 from 13 others

What the payments were for

Food & beverage$1,997100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	39	$458
Lilly USA, LLC	11	$345
Takeda Pharmaceuticals U.S.A., Inc.	12	$302
Esperion Therapeutics, Inc.	10	$247
AbbVie	6	$200
Sanofi-aventis U.S. LLC	1	$133
Currax Pharmaceuticals LLC	4	$61
Pfizer	2	$46
Idorsia Pharmaceuticals US Inc	2	$37
Lundbeck LLC	1	$32
Otsuka America Pharmaceutical, Inc.	2	$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$17
Bayer	1	$15
Exact Sciences	1	$13
Eisai Inc.	1	$13
Biohaven Pharmaceutical Holding Company Ltd.	1	$13
Mylan Specialty L.p.	1	$13
AstraZeneca	1	$11
Clarus Therapeutics Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,997 in reported general payments places this provider in the 75th percentile of 170 adult health providers in Kentucky.

See all adult health providers in Kentucky →

Other adult health in Louisville

Stephanie FlaspoehlerLouisville$174K
Heidi GalloLouisville$15K
Karen EastridgeLouisville$10K
Barbara CarpenterLouisville$8K
Loren GarzaLouisville$6K
Kelly MikeLouisville$4K
Layla Al-ShamiLouisville$3K
Brittany McWhorterLouisville$3K
Lahoma PratherLouisville$2K
William NapierLouisville$2K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →